---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-042744"
form_type: "8-K"
ticker: "CODX"
cik: "0001692415"
company_name: "Co-Diagnostics, Inc."
filed_at: "2026-09-15T20:05:28+00:00"
generated_at: "2026-09-15T20:06:38.518098+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Co-Diagnostics signs MTA with ReadyGo to test sample prep tech on Co-Dx PCR platform

## Summary
- In August 2026, Co-Diagnostics entered a material transfer agreement with ReadyGo Diagnostics Ltd to evaluate ReadyGo's sample collection/preparation tech.
- Evaluation covers compatibility of ReadyGo's sample collection, lysis, stabilization, and prep technologies with Co-Dx PCR platform.
- ReadyGo will supply sampling materials for feasibility studies; no obligation for further development, supply, or commercialization.
- Co-Dx PCR platform and tests are not yet FDA-approved and are not currently available for sale.

## SEC filing metadata
- accession: 0001493152-26-042744
- form_type: 8-K
- ticker: CODX
- cik: 0001692415
- company_name: Co-Diagnostics, Inc.
- filed_at: 2026-09-15T20:05:28+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1692415/000149315226042744/0001493152-26-042744-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1692415/000149315226042744/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-042744
- JSON: https://secwatch.observer/filing/0001493152-26-042744.json
- Plain text: https://secwatch.observer/filing/0001493152-26-042744.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.